SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

ZAULI, Giorgio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 31.430
AS - Asia 15.587
EU - Europa 9.497
SA - Sud America 2.602
Continente sconosciuto - Info sul continente non disponibili 677
AF - Africa 347
OC - Oceania 40
AN - Antartide 1
Totale 60.181
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 30.753
SG - Singapore 5.933
CN - Cina 3.767
IT - Italia 2.729
BR - Brasile 2.057
VN - Vietnam 1.766
DE - Germania 1.294
UA - Ucraina 1.288
HK - Hong Kong 1.234
TR - Turchia 900
GB - Regno Unito 869
PL - Polonia 858
FI - Finlandia 551
FR - Francia 461
BD - Bangladesh 418
RU - Federazione Russa 394
CA - Canada 361
JP - Giappone 332
SE - Svezia 326
IN - India 310
ID - Indonesia 224
NL - Olanda 221
MX - Messico 216
AR - Argentina 206
ZA - Sudafrica 147
IQ - Iraq 118
ES - Italia 108
EC - Ecuador 85
PK - Pakistan 81
CO - Colombia 68
BE - Belgio 65
UZ - Uzbekistan 59
SA - Arabia Saudita 57
VE - Venezuela 57
LT - Lituania 50
AT - Austria 43
CZ - Repubblica Ceca 41
MY - Malesia 40
CL - Cile 39
PH - Filippine 37
AU - Australia 35
EG - Egitto 34
MA - Marocco 33
PY - Paraguay 33
JO - Giordania 31
TN - Tunisia 27
AE - Emirati Arabi Uniti 26
KE - Kenya 26
IR - Iran 25
UY - Uruguay 23
AZ - Azerbaigian 22
CH - Svizzera 22
KR - Corea 22
IL - Israele 21
JM - Giamaica 21
AL - Albania 20
DZ - Algeria 20
IE - Irlanda 20
NP - Nepal 20
CR - Costa Rica 19
RO - Romania 18
PE - Perù 17
KZ - Kazakistan 16
EE - Estonia 15
DO - Repubblica Dominicana 14
ET - Etiopia 14
KG - Kirghizistan 14
LK - Sri Lanka 14
TW - Taiwan 14
BO - Bolivia 13
OM - Oman 13
TH - Thailandia 13
PS - Palestinian Territory 12
PT - Portogallo 12
BG - Bulgaria 11
RS - Serbia 11
HN - Honduras 10
LB - Libano 10
GE - Georgia 9
GT - Guatemala 9
TT - Trinidad e Tobago 9
HR - Croazia 8
SK - Slovacchia (Repubblica Slovacca) 8
SN - Senegal 8
GR - Grecia 7
MD - Moldavia 7
NO - Norvegia 7
BH - Bahrain 6
LV - Lettonia 6
CI - Costa d'Avorio 5
DK - Danimarca 5
HU - Ungheria 5
KW - Kuwait 5
BB - Barbados 4
CY - Cipro 4
EU - Europa 4
LY - Libia 4
NI - Nicaragua 4
PA - Panama 4
AO - Angola 3
Totale 59.435
Salva come PNG Salva come JPEG
Città #
Singapore 3.648
Ashburn 3.642
Fairfield 3.039
Woodbridge 2.830
San Jose 1.902
Houston 1.780
Jacksonville 1.387
Ann Arbor 1.271
Chandler 1.232
Seattle 1.214
Hong Kong 1.205
Santa Clara 1.182
Beijing 1.164
Cambridge 1.071
Wilmington 1.062
Warsaw 833
Ho Chi Minh City 580
Ferrara 565
Dallas 547
Los Angeles 543
Izmir 491
New York 478
Council Bluffs 471
Nanjing 391
Hanoi 386
Princeton 312
Tokyo 307
Milan 286
Lauterbourg 285
Boardman 258
Munich 254
San Diego 242
São Paulo 194
Helsinki 185
Shanghai 172
Jakarta 157
Orem 153
Buffalo 144
Bologna 136
Mexico City 128
Shenyang 128
Nanchang 125
London 120
Rome 117
Chicago 113
Dearborn 110
Montreal 105
Hefei 99
Tianjin 98
Denver 97
Brooklyn 91
Da Nang 91
Johannesburg 90
Turku 89
Toronto 88
Chennai 86
The Dalles 86
Frankfurt am Main 82
San Francisco 81
Changsha 77
Atlanta 75
Haiphong 70
Hebei 70
Moscow 67
Columbus 65
Stockholm 65
Jiaxing 64
Brussels 62
Dong Ket 62
Falls Church 61
Mountain View 60
Phoenix 58
Poplar 56
Bremen 55
Jinan 55
Boston 54
San Mateo 51
Rio de Janeiro 50
Norwalk 49
Zhengzhou 48
Manchester 47
Tashkent 47
Baghdad 46
Kunming 46
Mumbai 46
Auburn Hills 42
Falkenstein 42
Belo Horizonte 41
Curitiba 40
Redwood City 38
Verona 38
Ankara 37
Naples 37
Amsterdam 36
Hải Dương 36
Porto Alegre 35
Guangzhou 33
Nuremberg 33
Tappahannock 33
Quito 32
Totale 40.082
Salva come PNG Salva come JPEG
Nome #
Pharmaco-toxicological effects of the novel tryptamine hallucinogen 5-MeO-MiPT on motor, sensorimotor, physiological, and cardiorespiratory parameters in mice—from a human poisoning case to the preclinical evidence 791
Gene-gene interactions among coding genes of iron-homeostasis proteins and APOE-alleles in Cognitive Impairment Diseases 490
Trattato di Anatomia Umana 392
The synthetic cathinones MDPHP and MDPV: Comparison of the acute effects in mice, in silico ADMET profiles and clinical reports 366
Cell cycle block by p53 acrivation reduces SARS-COV-2 release in infected alveolar basal epithelial A549-hACE2 cells 347
Trattato di Anatomia Umana 336
Design, synthesis and biological characterization of novel mitochondria targeted dichloroacetate-loaded compounds with antileukemic activity 336
Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model 302
Targeting mTOR in Acute Lymphoblastic Leukemia 296
PI3K isoform inhibition associated with anti Bcr-Abl drugs shows in vitro increased anti-leukemic activity in Philadelphia chromosome-positive B-acute lymphoblastic leukemia cell lines 290
Cardiovascular disease-related miRNAs expression: Potential role as biomarkers and effects of training exercise 285
Changes of nuclear protein kinase C activity and isotype composition in PC12 cell proliferation and differentiation 280
Healthy CD4+ T lymphocytes are not affected by targeted therapies against the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia 280
Cell cycle block by p53 activation reduces SARS-CoV-2 release in infected alveolar basal epithelial A549-hACE2 cells 279
The anti-leukemic activity of sodium dichloroacetate in p53(mutated/null) cells is mediated by a p53-independent ILF3/p21 pathway 276
Intranasal Administration of Recombinant TRAIL Down-Regulates CXCL-1/KC in an Ovalbumin-Induced Airway Inflammation Murine Model 276
Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3 272
MDM2/X inhibitors under clinical evaluation: Perspectives for the management of hematological malignancies and pediatric cancer 271
Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia 268
A Brain Hidden in the Ferrara Cathedral: A Novel Interpretation of a Renaissance Masterpiece 266
Nutlin-3 up-regulates the expression of Notch1 in both myeloid and lymphoid leukemic cells, as part of a negative feedback antiapoptotic mechanism 263
COVID-19 and individual genetic susceptibility/receptivity: Role of ACE1/ACE2 genes, immunity, inflammation and coagulation. might the double x-chromosome in females be protective against SARS-COV-2 compared to the single x-chromosome in males? 263
Synergistic effects of selective inhibitors targeting the PI3K/AKT/mTOR pathway or NUP214-ABL1 fusion protein in human Acute Lymphoblastic Leukemia 259
Impact of physical exercise in cancer survivors during and after antineoplastic treatments 258
The novel dual PI3K/mTOR inhibitor NVP-BGT226 displays cytotoxic activity in both normoxic and hypoxic hepatocarcinoma cells 257
An autocrine loop of HIV type-1 Tat protein responsible for the improved survival/proliferation capacity of permanently tat-transfected cells and required for optimal HIV-1 LTR transactivating activity 256
Synergistic cytotoxic activity of recombinant TRAIL plus the non-genotoxic activator of the p53 pathway nutlin-3 in acute myeloid leukemia cells 253
Triple Akt inhibition as a new therapeutic strategy in T-cell acute lymphoblastic leukemia 252
Actively targeted nanocarriers for drug delivery to cancer cells 252
Antiangiogenic activity of the MDM2 antagonist nutlin-3 250
Conjunctival sac fluid contains elevated levels of soluble TRAIL: implications for the anti-tumoral surveillance of the anterior surface of the eye 250
Association between thyroid hormones and TRAIL 250
HelixComplex snail mucus exhibits pro-survival, proliferative and pro-migration effects on mammalian fibroblasts 250
Association of tumor necrosis factor-related apoptosis-inducing ligand with total and cardiovascular mortality in older adults 246
Oxidative stress: role of physical exercise and antioxidant nutraceuticals in adulthood and aging 244
Association of serum tumor necrosis factor-related apoptosis inducing ligand with body fat distribution as assessed by dual X-rays absorptiometry 243
All-trans retinoic acid shows multiple effects on the survival, proliferation and differentiation of human fetal CD34+ haemopoietic progenitor cells. 242
Roles and clinical implications of microRNAs in acute lymphoblastic leukemia 241
Targeting the phosphatidylinositol 3-kinase/Akt/mechanistic target of rapamycin signaling pathway in B-lineage acute lymphoblastic leukemia: An update 239
Serum Soluble Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Levels in Older Subjects with Dementia and Mild Cognitive Impairment 238
Cytokine levels in the serum of healthy subjects 236
Multiple dye-doped NIR-emitting silica nanoparticles for both flow cytometry and in vivo imaging 235
Physical training interventions for children and teenagers affected by acute lymphoblastic leukemia and related treatment impairments 234
TNF-related apoptosis inducing ligand in ocular cancers and ocular diabetic complications 230
Metformin combined with sodium dichloroacetate promotes B leukemic cell death by suppressing anti-apoptotic protein Mcl-1 230
Human bone marrow mesenchymal stem cells display anti-cancer activity in SCID mice bearing disseminated non-hodgkin's lymphoma xenografts 229
GM-CSF Exhibits Anti-Inflammatory Activity on Endothelial Cells Derived from Chronic Venous Disease Patients 229
Differential gene expression induction by TRAIL in B chronic lymphocytic leukemia (B-CLL) cells showing high versus low levels of Zap-70 228
TRAIL and Ceruloplasmin Inverse Correlation as a Representative Crosstalk between Inflammation and Oxidative Stress 228
The MDM-2 antagonist nutlin-3 promotes the maturation of acute myeloid leukemic blasts 227
Evidence for a role of TNF-related apoptosis-inducing ligand (TRAIL) in the anemia of myelodysplastic syndromes 227
The p53 transcriptional pathway is preserved in ATMmutated and NOTCH1mutated chronic lymphocytic leukemias 227
Circulating levels of frizzled-related protein (FRZB) are increased in patients with early rheumatoid arthritis and decrease in response to disease-modifying antirheumatic drugs. 226
The circulating levels of TRAIL are extremely low after delivery but rapidly recover in both mothers and newborns 226
Association of Soluble Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) with Central Adiposity and Low-Density Lipoprotein Cholesterol 224
Clinical perspectives of TRAIL: Insights into central nervous system disorders 222
TRAIL promotes the survival, migration and proliferation of vascular smooth muscle cells 221
Accuracy of intraocular lens power calculation for cataract surgery after deep anterior lamellar keratoplasty 220
Flow cytometric quantification of HIV-1 Tat protein in tat-transfected Jurkat T cell lines 219
Human Herpesvirus 7 infection induces profound cell cycle perturbations coupled to disregulation of cdc2 and cyclin B and polyploidization of CD4+ T Cells 217
Kinetic Profiles of Inflammatory Mediators in the Conjunctival Sac Fluid of Patients upon Photorefractive Keratectomy 217
Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets 217
Extracellular HIV-1 tat protein activates phosphatidylinositol 3- and Akt/PKB kinases in CD4+ T lymphoblastoid jurkat cells 216
In Vitro Characterization of Circulating Endothelial Progenitor Cells Isolated from Patients with Acute Coronary Syndrome 216
TRAIL counteracts the proadhesive activity of inflammatory cytokines in endothelial cells by down-modulating CCL8 and CXCL10 chemokine expression and release 215
Lovastatin dose-dependently potentiates the pro-inflammatory activity of lipopolysaccharide both in vitro and in vivo 215
Extracellular Tat activates c-fos promoter in low serum-starved CD4+ T cells 215
Functional integrity of the p53-mediated apoptotic pathway induced by the nongenotoxic agent nutlin-3 in B-cell chronic lymphocytic leukemia (B-CLL) 214
Applications of nanoparticles in cancer medicine and beyond: optical and multimodal in vivo imaging, tissue targeting and drug delivery 214
HIV-1 Tat-mediated inhibition of the tyrosine hydroxylase gene expression in dopaminergic neuronal cells 213
Nanoparticles Loaded with Nutlin-3 Display Cytotoxicity Towards p53(wild-type) JVM-2 But Not Towards p53(mutated) BJAB Leukemic Cells 213
Circulating TRAIL shows a significant post-partum decline associated to stressful conditions 212
In vivo anti-lymphoma activity of an agonistic human recombinant anti-TRAIL-R2 minibody. 211
Redox signaling and oxidative stress: Cross talk with TNF-related apoptosis inducing ligand activity 211
Stroma-derived factor 1α induces a selective inhibition of human erythroid development via the functional upregulation of Fas/CD95 ligand 209
Activated human NK and CD8+ T cells express both TNF-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors but are resistant to TRAIL-mediated cytotoxicity 209
Hydrogen sulfide down-regulates the expression and release of osteoprotegerin (OPG) by vascular endothelial cells 209
MDM2 antagonist Nutlin-3 suppresses the proliferation and differentiation of human pre-osteoclasts through a p53-dependent pathway 208
The Sorafenib plus Nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of the FLT3 and p53 status 208
Extracellular HIV-1 Tat protein differentially activates the JNK and ERK/MAPK pathways in CD4 T cells 206
Effects of hypoxia and bed rest on markers of cardiometabolic risk: Compensatory changes in circulating trail and glutathione redox capacity 205
Natural Killer Cells in SARS-CoV-2-Vaccinated Subjects with Increased Effector Cytotoxic CD56dim Cells and Memory-Like CD57+NKG2C+CD56dim Cells 204
Involvement of TRAIL/TRAIL-receptors in human intestinal cell differentiation 204
The MDM2 inhibitor Nutlin-3 attenuates streptozotocin-induced diabetes mellitus and increases serum level of IL-12p40. 204
In vitro growth of human fetal CD34+ cells in the presence of various combinations of recombinant cytokines under serum-free culture conditions 204
HIV-1 Tat protein down-regulates CREB transcription factor expression in PC12 neuronal cells through a phosphatidylinositol 3-kinase/AKT/cyclic nucleoside phosphodiesterase pathway 203
HIV-1 Tat induces tyrosine phosphorylation of p125(FAK) and its association with phosphoinositide 3-kinase in PC12 cells 202
Combined treatment of CpG-oligodeoxynucleotide with Nutlin-3 induces strong immune stimulation coupled to cytotoxicity in B-chronic lymphocytic leukemic (B-CLL) cells 202
Exogenous human immunodeficiency virus type‐1 Tat protein selectively stimulates a phosphatidylinositol‐specific phospholipase C nuclear pathway in the Jurkat T cell line 201
Influence of physical exercise on microRNAs in skeletal muscle regeneration, aging and diseases 201
Role of physical exercise in the regulation of epigenetic mechanisms in inflammation, cancer, neurodegenerative diseases, and aging process 201
Proper design of silica nanoparticles combines high brightness, lack of cytotoxicity and efficient cell endocytosis 199
SARS-CoV-2 nucleocapsid-protein and ultrastructural modifications in small bowel of a four week negative COVID-19 patient 199
Relationship between low levels of circulating TRAIL and atheromatosis progression in patients with chronic kidney disease 198
Heterogeneity of mesenchymal stromal cells in lymphoproliferative disorders 197
HIV-1 Tat protein concomitantly down-regulates apical caspase-10 and up-regulates c-FLIP in lymphoid T cells: A potential molecular mechanism to escape TRAIL cytotoxicity 196
Release of a specific set of proinflammatory adipokines by differentiating 3T3-L1 cells 196
Engagement of CD28 modulates CXC chemokine receptor 4 surface expression in both resting and CD3-stimulated CD4+ T cells 196
Multimodal near-infrared-emitting PluS Silica nanoparticles with fluorescent, photoacoustic, and photothermal capabilities 196
Molecular targets for selective killing of TRAIL-resistant leukemic cells. 195
Totale 24.491
Salva come PNG Salva come JPEG
Categoria #
all - tutte 256.381
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.162
Totale 259.543
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.048 109 312 243 136 158 180 158 177 119 257 363 836
2022/20233.019 334 136 119 357 462 472 103 271 387 52 186 140
2023/20241.541 179 207 73 42 106 195 61 147 42 41 64 384
2024/20257.965 257 192 604 332 995 610 356 485 1.372 775 1.125 862
2025/202622.600 2.133 961 1.984 2.733 3.033 1.508 2.515 1.271 2.081 2.527 1.237 617
2026/2027886 886 0 0 0 0 0 0 0 0 0 0 0
Totale 60.181